chartexchange

TNYA
Tenaya Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 17, 2026 11:44:10 AM EST
0.32USD-4.826%(-0.02)3,523,031
Pre-marketNov 17, 2026 9:25:30 AM EST
0.333USD-0.180%(-0.001)
0.2900Bid0.3800Ask0.0900Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
South San Francisco, CA, USA
Previous Close
$0.33
Beta
2.56
52-Week High
$1.46 2025-12-10
52-Week Low
$0.30 2026-11-05
SMA 50
$0.50
SMA 200
$0.69
Avg. Vol 10D
2.52M
Avg. Vol 30D
3.34M
Avg. Vol 90D
2.57M
Relative Vol
1.04
227.93M
215.42M
23,407,267
0.5100%
1,100,000
386
TNYA Profile

tenaya therapeutics is a privately-held biopharmaceutical company backed by the column group. the company was founded in 2016 by world-leading scientists from the gladstone institute's cardiovascular division and the university of texas southwestern medical center. tenaya is dedicated to addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration. tenaya has a lead gene therapy program focused on in vivo reprogramming of cardiac fibroblasts to cardiomyocytes to regenerate heart tissue, and additional programs focused on cardiomyopathies.

TNYA Performance
PeriodPriceDateChangeBeta
1W0.372026-11-10-14.38%1.435
1M0.382026-10-16-16.65%3.132
3M0.702026-08-17-54.68%3.068
6M0.782026-05-18-59.48%2.142
1Y1.262025-11-17-74.82%2.557
2Y2.062024-11-18-84.60%—
5Y21.312021-11-17-98.51%1.886
TNYA Stock Summary

Tenaya Therapeutics, Inc. Common Stock (NASDAQ:TNYA) stock price today is $0.32, and today's volume is 3,482,299. TNYA is down 4.886% today. The 30 day average volume is 3.34M. TNYA market cap is $72.32M with 227.93M shares outstanding.